Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.
Cowen & Co. Downgrades Graphite Bio to Market Perform
Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.
Related Posts
GeoVax Shares Up 23%; Co Earlier Reported In Form4 Filing Director Randal Chase Bought 10K Shares At Average Price Of $1.10/Share
Today, 10:22 AM
-SEC Filing-SEC Filing
Why Ethereum Classic Could Get Slaughtered Amid Bitcoin, Ethereum Pullback If This Pattern Plays Out
Today, 10:22 AM
Ethereum Classic (CRYPTO: ETC) fell 13.21% on Tuesday before bouncing to just above a support level at $50.78.
White House Says Senior Staff Has Followed Up With McCarthy’s Office After Spending Talks
Today, 10:22 AM
- Reuters